Process for the preparation of a medium-chain triglyceride composition and medium-chain triglyceride composition
By introducing specifically surface-modified inorganic nano-silica hybrid materials into medium-chain triglycerides, a stable lipid carrier platform was constructed, solving the problems of stability and drug loading capacity of medium-chain triglycerides in biopharmaceuticals, and achieving efficient and safe drug delivery and targeting functions.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HUBEI CHUYI NEW MATERIAL CO LTD
- Filing Date
- 2026-03-11
- Publication Date
- 2026-06-19
AI Technical Summary
Existing medium-chain triglycerides face challenges in biopharmaceutical applications, including insufficient physical stability, limited drug loading capacity, and the need to improve biocompatibility, making it difficult to meet the high-requirement formulation needs.
By introducing a specifically surface-modified inorganic nano-silica hybrid material and combining it with a medium-chain triglyceride lipid matrix, a kinetically stable dispersion system is formed. The multifunctional groups of the modified material generate various interactions with drug molecules, thus constructing a stable lipid carrier platform.
This study improved the physicochemical stability of medium-chain triglyceride compositions under long-term storage and temperature fluctuation conditions, broadened the drug loading capacity for different drugs, optimized biocompatibility, and provided flexible functional upgrade capabilities.
Smart Images

Figure SMS_1